We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$1.34B
AUM Growth
+$22.1M
Cap. Flow
-$5.89M
Cap. Flow %
-0.44%
Top 10 Hldgs %
17.53%
Holding
751
New
49
Increased
312
Reduced
289
Closed
31

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.23M
2
JNJ icon
Johnson & Johnson
JNJ
+$5.15M
3
IBM icon
IBM
IBM
+$3.32M
4
CPB icon
Campbell Soup
CPB
+$2.43M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.05M

Sector Composition

Rank Sector Weight
1 Financials 12.84%
2 Healthcare 12.71%
3 Technology 11.57%
4 Consumer Staples 9.8%
5 Industrials 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEG icon
101
Public Service Enterprise Group
PEG
$39.8B
$3.41M 0.25%
79,328
+11,531
+17% +$510K
VTI icon
102
Vanguard Total Stock Market ETF
VTI
$654B
$3.35M 0.25%
26,930
+2,144
+9% +$264K
RSP icon
103
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$3.3M 0.25%
35,638
-1,310
-4% -$120K
VFC icon
104
VF Corp
VFC
$6.68B
$3.3M 0.25%
60,896
+1,474
+2% +$76.1K
WHR icon
105
Whirlpool
WHR
$2.42B
$3.22M 0.24%
16,813
+229
+1% +$41.9K
NKE icon
106
Nike
NKE
$61.9B
$3.16M 0.24%
53,550
-3,758
-7% -$203K
EMR icon
107
Emerson Electric
EMR
$82.9B
$3.15M 0.24%
52,846
+1,648
+3% +$97.7K
VOD icon
108
Vodafone
VOD
$34.9B
$3M 0.22%
104,259
-6,942
-6% -$193K
DD icon
109
DuPont de Nemours
DD
$18.6B
$2.98M 0.22%
18,630
+314
+2% +$49.9K
DVY icon
110
iShares Select Dividend ETF
DVY
$24B
$2.94M 0.22%
31,874
-393
-1% -$36.1K
C icon
111
Citigroup
C
$222B
$2.88M 0.22%
43,141
+3,517
+9% +$216K
EPD icon
112
Enterprise Products Partners
EPD
$83.8B
$2.88M 0.22%
106,497
-2,785
-3% -$75.5K
MDT icon
113
Medtronic
MDT
$107B
$2.87M 0.21%
32,373
+1,850
+6% +$156K
USB icon
114
US Bancorp
USB
$99.6B
$2.82M 0.21%
54,336
+1,177
+2% +$60.6K
IJR icon
115
iShares Core S&P Small-Cap ETF
IJR
$109B
$2.75M 0.21%
39,244
-3,627
-8% -$251K
NSC icon
116
Norfolk Southern
NSC
$78.8B
$2.74M 0.2%
22,500
-229
-1% -$26.9K
EMN icon
117
Eastman Chemical
EMN
$7.8B
$2.71M 0.2%
32,221
+5,246
+19% +$423K
MDLZ icon
118
Mondelez International
MDLZ
$77.7B
$2.68M 0.2%
61,986
-1,025
-2% -$46.2K
NVS icon
119
Novartis
NVS
$295B
$2.65M 0.2%
35,365
-11,468
-24% -$813K
VNQ icon
120
Vanguard Real Estate ETF
VNQ
$39.9B
$2.59M 0.19%
31,135
+1,492
+5% +$124K
VWO icon
121
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$2.58M 0.19%
63,255
-6,407
-9% -$260K
CCL icon
122
Carnival Corporation Ltd
CCL
$36.1B
$2.57M 0.19%
39,261
+1,587
+4% +$98.9K
AXP icon
123
American Express
AXP
$223B
$2.48M 0.19%
29,411
-24,279
-45% -$1.92M
WELL icon
124
Welltower
WELL
$178B
$2.46M 0.18%
32,921
-35
-0.1% -$2.56K
IGIB icon
125
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.3B
$2.38M 0.18%
43,372
+16,446
+61% +$902K

Similar funds

Raymond James Trust's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James Trust held 751 positions worth $1.34B, up 1.7% from $1.32B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James Trust's Q2 2017 filing shows 49 new, 312 increased, 289 reduced and 31 closed positions. Its largest new stake was AutoZone: 801 shares worth $457K. The largest sale was Merck, an estimated $5.23M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Technology.

  • Raymond James Trust's largest Q2 2017 buy was AutoZone: 801 shares worth $457K.
  • Raymond James Trust added most to Alphabet (Google) Class C in Q2 2017, an estimated $2.2M increase.
  • Raymond James Trust's biggest Q2 2017 reduction was Merck, cutting an estimated $5.23M.
  • Raymond James Trust fully exited Campbell Soup in Q2 2017, selling an estimated $2.43M.
  • Raymond James Trust's ten largest holdings make up 18% of its $1.34B portfolio in Q2 2017.
  • Raymond James Trust opened 49 new positions and closed 31 in Q2 2017.
  • Raymond James Trust's portfolio value rose 1.7% quarter-over-quarter to $1.34B.

Based on Raymond James Trust's 13F filing for Q2 2017, filed 10 Aug 2017.